Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
---|
09/25/2008 | US20080233119 Modulating death receptor 3 and/or CD30 function; interleukin expression inhibition |
09/25/2008 | US20080233067 Method Of Making Enhanced Efficacy Antiperspirant Actives |
09/24/2008 | EP1601374B1 Compositions and methods for diagnosing and treating an inflammation |
09/24/2008 | EP1035825B2 Hair colorant preparation |
09/24/2008 | CN100420717C Compositions comprising anionic functionalized polyorganosiloxanes for hydrophobically modifying surfaces and enhancing delivery of active agents to surfaces treated therewith |
09/23/2008 | US7427681 Anticancer agents; antidiabetic agents; Alzheimer's disease |
09/23/2008 | US7427639 β2-adrenergic receptor agonists |
09/23/2008 | US7427637 Kinesin spindle protein (KSP) inhibitors; antiproliferative and -carcinogenic agents; side effects reduction; used with an estrogen receptor modulator; e.g. bicyclic dihydropyrrole derivatives |
09/23/2008 | US7427629 Immunostimulatory compositions and methods of stimulating an immune response |
09/23/2008 | US7427622 Method of making and using theaflavin, theaflavin-3-gallate, theaflavin-3′-gallate and theaflavin 3,3′-digallate and mixtures thereof |
09/23/2008 | US7427589 Administering substance that inhibits a pro-inflammatory cytokine for prevention or reduction of scar tissue and/or adhesion formation |
09/23/2008 | CA2432872C Pyrazole compounds useful as protein kinase inhibitors |
09/23/2008 | CA2378390C Tixocortol pivalate suspension, collutorium based on it and packaging containing it |
09/18/2008 | US20080228239 Systems And Methods For Altering Vestibular Biology |
09/18/2008 | US20080228069 Novel Differential Imaging Method |
09/18/2008 | US20080227862 histone deacetylase (HDAC) inhibitor useful in selectively inducing terminal differentiation, cell growth arrest and/or apoptosis of neoplastic cells; have a high bioavailability and gives high blood levels of the active compounds over a long time |
09/18/2008 | US20080227810 6-Cycloamino-2-quinolinone derivatives as androgen receptor modulator compounds |
09/18/2008 | US20080227804 Polymorphic solvates of naltrexone with ethanol, benzyl alcohol, dimethylformamide, methanol, dichloromethane, acetone and hexane; sustained release formulations |
09/18/2008 | US20080227778 6-Methoxy-3-(methoxymethyl)-2-methyl-4-phenylisoquinolin-1(2H)-one; treat cardiac arrhythmias |
09/18/2008 | US20080227703 neublastin neurotrophic factor polypeptides for treating neuropathy |
09/18/2008 | US20080227121 Using collagen XIII peptide as evaluative tool in identifying modulators monocyte efflux into interstitial space; treating chronic inflammatory disorders |
09/18/2008 | US20080227114 Compositions and methods for modulating c-rel-dependent cytokine production |
09/18/2008 | US20080226671 Deactivation or attenuation Mycoplasma vaccine for cattle; side effect reduction; respiratory system disorders ; mammary disorders; joint, eye, ear infections |
09/18/2008 | US20080226666 Immunogenic polypeptide for protecting pigs against viral infection or postweaning multisystemic wasting syndrome |
09/18/2008 | US20080226558 Mesoderm and definitive endoderm cell populations |
09/17/2008 | EP1409477B1 Piperidine derivatives as nmda receptor antagonists |
09/17/2008 | CN101265262A New oxabispidine compounds useful in the treatment of cardiac arrhythmias |
09/17/2008 | CN101265226A Compounds and methods for delivery of prostacyclin analogs |
09/17/2008 | CN101264093A Compositions for increasing energy in vivo |
09/17/2008 | CN100418967C Tricyclic inhibitors of poly(ADP-ribose) polymerases |
09/17/2008 | CN100418585C Stable radiopharmaceutical compositions and methods for preparation |
09/17/2008 | CN100418576C Subcutaneously-administered ganglioside-based vaccine compositions |
09/17/2008 | CN100418533C Pharmaceutical combinations of cox-2 inhibitors and opiates |
09/17/2008 | CN100418506C Anti-germ attachment composition |
09/16/2008 | US7425565 Use of benzothiopenes to treat and prevent prostate cancer |
09/16/2008 | US7425547 Nucleoside derivatives for treating hepatitis C virus infection |
09/16/2008 | US7425325 binding ligands and proteins comprising amino acid sequences, having high specificity for the receptor zcytor17, used to induce proinflammatory cytokine production, for stimulating the immune system and proliferation and/or development of hematopoietic cells in vitro and in vivo; antibodies |
09/16/2008 | CA2427221C Process and intermediates for preparing anti-cancer compounds |
09/16/2008 | CA2120732C Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction |
09/16/2008 | CA2110730C Sustained-release preparation |
09/12/2008 | WO2004078116A9 P38 inhibitors and methods of use thereof |
09/11/2008 | US20080221191 Mycobacterium tuberculosis infection; protozoan pathogens; fungal pathogens |
09/11/2008 | US20080221098 Compounds and compositions as protein kinase inhibitors |
09/11/2008 | US20080221065 Pharmaceutical formulations; epothilone and mannitol or a cyclodextrin parenteral administration in the form of an infusion concentrate or lyophilised composition |
09/11/2008 | US20080216606 Grinding to uniform particle size; heating; pressurization;; extraction from ores, concentrates |
09/10/2008 | EP1551417B1 Three layer tear formulation |
09/10/2008 | EP1077691B1 Gamma-aminobutyric acid derivatives containing, solid compositions and process for preparing the same |
09/10/2008 | CN101263143A Crystalline forms of a pyrrolotriazine compound |
09/10/2008 | CN101260152A Method for down-regulating Osteoprotegerin ligand activity |
09/10/2008 | CN100417394C Application of plant extract for preparing medicine to cure bone absorption increment diseases and composition thereof |
09/09/2008 | US7424706 Automatic detection and patching of vulnerable files |
09/09/2008 | US7423123 Interleukin-9 antagonist muteins and their pharmacological methods of use |
09/09/2008 | US7423031 Compounds and compositions as protein kinase inhibitors |
09/09/2008 | US7423013 Protein formulation |
09/09/2008 | US7423004 Provide improved solubility and dissolution, as well as enhanced bioavailability of particulate pharmaceuticals; without the need for using organic solvents and without the need to heat the compound to temperatures above its melting point |
09/09/2008 | CA2304703C Skin-compatible hand cleansers, particularly coarse hand cleansers |
09/09/2008 | CA2287881C Vitamin d3 analogs with bis c-20 side chains |
09/09/2008 | CA2263445C Pharmaceutical aerosol composition |
09/04/2008 | WO2005025489A3 Therapeutic use of g53135-05(fgf-20) in radiation protection |
09/04/2008 | US20080214812 Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition |
09/04/2008 | US20080214655 Paclitaxel or a paclitaxel analog and 2,5-Dimethoxythiobenzoic acid N-methylhydrazine; antitumor; nontoxic |
09/04/2008 | US20080214640 3'-{[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2'-hydroxybiphenyl-3-carboxylic acid or a salt; treatment of thrombocytopenia; may be coadministered with a colony stimulating factor, cytokine, chemokine, or an interleukin or cytokine receptor agonist or antagonist |
09/04/2008 | US20080213351 Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease |
09/04/2008 | US20080213301 Compositions and methods for healthy pregnancy |
09/04/2008 | US20080213211 Compositions and methods for healthy pregnancy |
09/03/2008 | EP1964921A2 The high bone mass gene of 11q13.3 |
09/03/2008 | EP1964850A2 Compositions and methods for the treatment and diagnosis of breast cancer |
09/03/2008 | EP1605862A4 Collagen compositions and biomaterials |
09/03/2008 | CN101257928A Optical imaging contrast agents |
09/03/2008 | CN101255425A OX2 receptor homolog |
09/03/2008 | CN101254302A Treatment of autoimmune diseases with antagonists which bind to b cell surface markers |
09/03/2008 | CN100415737C Indole derivatives useful for treatment of CNS disorders |
09/03/2008 | CN100415735C Amino alcohol derivatives |
09/03/2008 | CN100415222C Methods of using and compositions comprising dopamine reuptake inhibitors |
09/03/2008 | CN100415188C Condom with erectogenic composition |
09/02/2008 | US7420037 Heat shock protein-based vaccines and immunotherapies |
09/02/2008 | US7419964 Treatment of HSV-related pathologies using ssDNA |
09/02/2008 | US7419779 Contacting compound with sumo protease polypeptide; measuring ligand or substrate binding; short interference RNA inhibits gene expression |
09/02/2008 | US7419687 carriers for group IB compounds such as silver nitrate comprising beads made of inert polymers, ceramics or stainless steels, used for treatment of menorrhagia |
09/02/2008 | US7419680 For therapy and prophylaxis of osteoporosis and for bone and fracture repair; slow-releasing, will promote bone formation and inhibit bone resorption |
09/02/2008 | US7419672 Genes and proteins, and their use |
09/02/2008 | US7419653 Method for preparing radiolabeled thymidine having low chromophoric byproducts |
09/02/2008 | CA2273023C Aminoguanidines and alkoxyguanidines as protease inhibitors |
09/02/2008 | CA2243237C Use of valaciclovir for the manufacture of a medicament for the treatment of genital herpes by a single daily application |
08/28/2008 | US20080208266 System and Method for Treating Nausea and Vomiting by Vagus Nerve Stimulation |
08/28/2008 | US20080206738 Reduce concentration of nitric oxide ; antiinflamamtory agents, stroke, antiproliferative agents; gastrointestinal disorders; inflammatory bowel disorders; antiarthritic agents; Parkinson's disease; Alzheimer's disease;amyotroic lateral sclerosis; anticancer agents |
08/28/2008 | US20080206335 Inert non-pareil core, fluvoxamine layer over core, rate-controlling membrane coating; fluvoxamine released over a period of 12 hours or more; once-daily oral administration |
08/28/2008 | US20080206269 stimulate the resuscitation of bacteria after true dormancy; cognate receptors, convertases, respective genes and inhibitors or mimetics |
08/28/2008 | US20080206265 Using oligonucleotide immunostimulant mixture with drug; Modification of an immunostimulatory oligonucleotide to optimally present 5' ends dramatically enhances its anti-cancer activity |
08/28/2008 | US20080206219 Using cytokine modulators as therapeutic tools in treatment of vascular permeability disorders |
08/28/2008 | US20080206189 Using water-soluble polymer conjugated interleukin-18 as therapeutic in treatment and prevention of cell proliferative disorders |
08/28/2008 | US20080206141 Optical Imaging Contrast Agents |
08/28/2008 | DE10164893B4 Verfahren zur Herstellung von Artischockenblätterextrakten und so erhaltene Artischockenblätterextrakte Process for the preparation of artichoke leaf extracts and extracts so obtained artichoke leaves |
08/27/2008 | EP1961811A1 Novel cytokine ZCYTOR17 ligand |
08/27/2008 | EP1622569A4 Aza spiro alkane derivatives as inhibitors of metallproteases |
08/27/2008 | EP1210078B1 Improved topical medicaments and methods for photodynamic treatment of disease |
08/27/2008 | CN100413860C Piperidine derivative as NMDA receptor antagonist |
08/27/2008 | CN100413849C Benzimidazole derivatives |
08/27/2008 | CN100413576C Encapsulated essential oils |
08/26/2008 | US7417158 Mycobacterium tuberculosis infection; protozoan pathogens; fungal pathogens |